Lower cash prices do not guarantee insurance coverage, and in some cases, including Medicaid programs, weight-loss-only coverage has narrowed rather than expanded
One option is the wearable device TENS therapy Enso , available through Hinge Health
Three FDA-approved GLP-1 medications are eligible under the bridge program when used to reduce excess body weight and maintain weight reduction: Wegovy (semaglutide), available as a weekly injection or daily oral tablet, manufactured by Novo Nordisk Zepbound (tirzepatide), available in the KwikPen autoinjector format, manufactured by Eli Lilly Foundayo (orforglipron), the first non-peptide, small-molecule oral GLP-1 for weight loss, recently FDA-approved and manufactured by Eli Lilly Each of these medications works by mimicking the activity of glucagon-like peptide-1, a hormone that regulates appetite, fullness, and blood sugar
This matches what I see in my practice
Net weight 29.4 g